Zoetis Inc. [NYSE: ZTS] stock went on a downward path that fall over -0.40% on Thursday, amounting to a one-week price decrease of less than -0.57%. The company report on June 10, 2021 that Zoetis A.L.P.H.A. Initiative Improves Livestock Health and Farmers’ Livelihoods in Sub-Saharan Africa with 1.7 billion Doses of Vaccines and Medicines administered in Four Years.
After four years of co-funding from Zoetis and the Bill & Melinda Gates Foundation, smallholder farms improve productivity thanks to new diagnostics, vaccines and treatments.
Livestock health and farmers’ livelihoods have been dramatically improved in Sub-Saharan Africa, following the administration of 1.7 billion doses of vaccines and medicines and over 650,000 diagnostic tests through Zoetis’ African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative, now in its fourth year.
Over the last 12 months, ZTS stock rose by 38.03%. The one-year Zoetis Inc. stock forecast points to a potential upside of 3.08. The average equity rating for ZTS stock is currently 1.90, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $88.51 billion, with 475.50 million shares outstanding and 473.70 million shares in the current float. Compared to the average trading volume of 1.78M shares, ZTS stock reached a trading volume of 1630719 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Zoetis Inc. [ZTS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZTS shares is $191.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZTS stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Zoetis Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 08, 2021. The new note on the price target was released on March 08, 2021, representing the official price target for Zoetis Inc. stock. Previously, the target price had yet another raise to $191, while Atlantic Equities analysts kept a Overweight rating on ZTS stock.
The Average True Range (ATR) for Zoetis Inc. is set at 2.85, with the Price to Sales ratio for ZTS stock in the period of the last 12 months amounting to 12.62. The Price to Book ratio for the last quarter was 21.56. Price to Free Cash Flow for ZTS in the course of the last twelve months was 69.26 with Quick ratio for the last quarter at 2.50.
ZTS Stock Performance Analysis:
Zoetis Inc. [ZTS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.57. With this latest performance, ZTS shares gained by 4.96% in over the last four-week period, additionally plugging by 14.55% over the last 6 months – not to mention a rise of 38.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZTS stock in for the last two-week period is set at 65.61, with the RSI for the last a single of trading hit 65.11, and the three-weeks RSI is set at 64.74 for Zoetis Inc. [ZTS]. The present Moving Average for the last 50 days of trading for this stock 175.07, while it was recorded at 186.02 for the last single week of trading, and 164.18 for the last 200 days.
Insight into Zoetis Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Zoetis Inc. [ZTS] shares currently have an operating margin of +33.99 and a Gross Margin at +66.79. Zoetis Inc.’s Net Margin is presently recorded at +24.54.
Return on Total Capital for ZTS is now 22.11, given the latest momentum, and Return on Invested Capital for the company is 16.93. Return on Equity for this stock inclined to 50.58, with Return on Assets sitting at 13.02. When it comes to the capital structure of this company, Zoetis Inc. [ZTS] has a Total Debt to Total Equity ratio set at 196.39. Additionally, ZTS Total Debt to Total Capital is recorded at 66.26, with Total Debt to Total Assets ending up at 54.39. Long-Term Debt to Equity for the company is recorded at 179.30, with the Long-Term Debt to Total Capital now at 60.50.
Reflecting on the efficiency of the workforce at the company, Zoetis Inc. [ZTS] managed to generate an average of $144,956 per employee. Receivables Turnover for the company is 6.36 with a Total Asset Turnover recorded at a value of 0.53.Zoetis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.50 and a Current Ratio set at 3.30.
ZTS Stock EPS
With the latest financial reports released by the company, Zoetis Inc. posted 0.89/share EPS, while the average EPS was predicted by analysts to be reported at 0.64/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 39.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZTS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zoetis Inc. go to 12.53%.
Zoetis Inc. [ZTS] Insider Position Details
There are presently around $80,423 million, or 93.50% of ZTS stock, in the hands of institutional investors. The top three institutional holders of ZTS stocks are: BLACKROCK INC. with ownership of 39,468,145, which is approximately -3.076% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 37,065,794 shares of the stock with an approximate value of $6.87 billion in ZTS stocks shares; and STATE STREET CORP, currently with $3.52 billion in ZTS stock with ownership of nearly -2.345% of the company’s market capitalization.
Positions in Zoetis Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 725 institutional holders increased their position in Zoetis Inc. [NYSE:ZTS] by around 24,915,627 shares. Additionally, 583 investors decreased positions by around 23,177,840 shares, while 202 investors held positions by with 385,733,687 shares. The mentioned changes placed institutional holdings at 433,827,154 shares, according to the latest SEC report filing. ZTS stock had 117 new institutional investments in for a total of 3,017,762 shares, while 107 institutional investors sold positions of 1,165,348 shares during the same period.